CRNX vs CTLT
Crinetics Pharmaceuticals Inc (CRNX) versus CTLT (CTLT) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
CTLT (CTLT) common stock.
Latest reported CRNX revenue for 2026-06-30 was $35.9M. Net income was -$248.7M. CRNX currently screens at market cap $2.76B.
CTLT does not have a complete income-statement cache yet.
CRNX currently screens at market cap $2.76B.
Not investment advice. Open the CRNX and CTLT stock pages for the full models.
Not investment advice.